Cargando…
Erlotinib Induced Trichomegaly of the Eyelashes
Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. A...
Autores principales: | Jeon, Sang-Hoon, Ryu, Jeong-Seon, Choi, Gwang-Seong, Kim, Jung-Soo, Kwon, Hea-Yoon, Kim, Min-Su, Nam, Hae-Seong, Cho, Jae-Hwa, Kwak, Seung-Min, Lee, Hong Lyeol, Kim, Hyun-Jung, Hong, Geun-Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563702/ https://www.ncbi.nlm.nih.gov/pubmed/23390452 http://dx.doi.org/10.4046/trd.2013.74.1.37 |
Ejemplares similares
-
Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
por: Goel, Varun, et al.
Publicado: (2014) -
Eyelash Trichomegaly
por: Kaur, Sandeep, et al.
Publicado: (2015) -
Essential Trichomegaly of the Eyelashes
por: Fernández-Crehuet, Pablo, et al.
Publicado: (2016) -
Dramatic response of acute disseminated intravascular coagulation to erlotinib in a patient with lung adenocarcinoma with activating EGFR mutation
por: Kim, Jung Soo, et al.
Publicado: (2017) -
Eyelashes Trichomegaly: An Unusual Side Effect of Gefitinib Therapy
por: Agrawal, Chaturbhuj R, et al.
Publicado: (2018)